Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin plus clopidogrel for prevention of ischemic complications in endovascular coiling of unruptured cerebral aneurysm
IRCT20141209020258N198Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in brain aneurysm (IA) comparing Aspirin + clopidogrel with Placebo / no antiplatelet therapy (2 arms). Primary endpoints: Cerebral ischemic events and Stroke. Started Aug 2025; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on IRCT20141209020258N198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N198.